Skip to content

Impact of Screens on Children's Growth

Impact of Screens on Children's Growth

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07026812
Acronym
ECROIPED
Enrollment
150
Registered
2025-06-18
Start date
2022-09-26
Completion date
2025-06-01
Last updated
2025-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Growth Disorders

Keywords

Growth hormone

Brief summary

Short stature is defined as a height less than -2 Standard Deviations (SD) for age and a slowing of growth velocity by a loss of 1 SD/year. The causes of short stature are multiple (chronic diseases, growth hormone deficiency, hypothyroidism, hyperadrenocorticism, genetic syndromes, etc.). However, nearly 30% are considered idiopathic, with no identified etiology (Naccache et al., unpublished). Growth hormone (GH) is secreted in a pulsatile manner with maximum peaks primarily at night, raising questions about the relationship between sleep disturbances and short stature. In children, one of the main causes of sleep disturbances in the digital age is screen use, which is becoming increasingly important, particularly in the pediatric population.

Detailed description

During the night, physiologically, the retina, which no longer receives light signals, sends a message to the suprachiasmatic nucleus, the main key element of the internal clock, and to the pineal gland, which synthesizes melatonin, the sleep hormone. Exposing screens to blue light therefore disrupts melatonin secretion, which leads to a disruption of the circadian rhythm and therefore sleep. Note that this effect of light on melatonin secretion depends on the time of day of exposure, the intensity, and the duration. Thus, exposure to screens before bedtime can be responsible for a delay or even an absence of melatonin synthesis, particularly in the case of nighttime awakenings. While many studies have examined the impact of screens on children's psychological balance, weight, etc., none, to our knowledge, has examined the potential impact of screens on children's height growth. Hypothesis of this project: 70% of GH synthesis takes place at night, a few minutes after entering slow-wave sleep, sleep disturbed by screens could mean a lower secretion of GH and consequently a delay in height growth. The objective of this project is to evaluate the impact of screen consumption on sleep and the impact of sleep on idiopathic growth disorder.

Interventions

None listed

Sponsors

University Hospital, Rouen
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* Children aged 6 to 16 years old coming to the day hospital for a growth hormone stimulation test or an oral provocation test (without growth disorders) * Not opposed to participating in the study * Patients affiliated with the Social Security system

Exclusion criteria

* Growth hormone deficiency confirmed by 2 tests * Hypothyroidism * Hypercorticism * All chronic diseases * Skeletal pathologies: Turner syndrome, constitutional bone disease Intrauterine growth retardation * Pubertal delay defined by absence of puberty onset \>13 years in girls and 14 years in boys * Patient under guardianship

Design outcomes

Primary

MeasureTime frameDescription
Screen consumption on sleepAt enrollment visitEvaluation of the Impact of Screen Consumption on Sleep by Answers to the Questionnaire Given to the Child and/or Parent(s) (Depending on Age)
Impact of sleep on idiopathic growth disorderAt enrollment visitCollection of auxological data at the time of the day hospital consultation (height) noted in the health record and/or in the hospital medical file

Secondary

MeasureTime frameDescription
Impact of screens on body size (BMI)At enrollment visitEvaluation of the impact of screens on body size (BMI) by response to the questionnaire given to the child and/or the parent(s)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026